|Bid||0.00 x 4000|
|Ask||0.00 x 2200|
|Day's Range||33.92 - 34.05|
|52 Week Range||31.35 - 36.35|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.06%|
President Trump’s decision to withdraw from the Joint Comprehensive Plan of Action (or JCPOA) could lead to regional conflicts in the Middle East. Israel and Saudi Arabia, two of Iran’s neighbors, have extended support to President Trump’s decision, which could escalate the tensions in the region. Stock prices of energy (XLE) companies like Marathon Oil (MRO) and Hess have zoomed higher since the Iran deal pull-out and look set for further gains if crude prices continue to surge.
The world is full of model ETF portfolios, but we’re just starting to see the environmental, socially responsible and governance (ESG) filter as a consideration on many. The biggest recent news on this front was the development by robo-platform Betterment of an ESG version of its core portfolio last month.
Several of this year's top asset-gathering exchange traded funds are products focusing on developed market equities outside the U.S. Amid the rush to developed market ex-U.S. ETFs, another theme is becoming ...
Revenues for Sandoz are expected to report operational growth in 2Q17 following an increased demand for biopharmaceuticals.
Headquartered in Basel, Switzerland, Novartis (NVS) is a pharmaceutical company specializing in the research, development, manufacturing, and marketing of a broad range of healthcare products, mainly pharmaceuticals. ...
The Pharmaceuticals segment reported an operational growth of 4.0% and a 13.0% positive impact of foreign exchange, resulting in a rise of 17.0% in revenues.
A few of the segments AstraZeneca identifies as growth platforms include Respiratory products, new Cardiovascular and Metabolic Diseases products, and new Oncology products.